This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JACC Specialty Journals
JACC: CardioOncology - Prognosis of Transthyretin Cardiac Amyloidosis without Heart Failure Symptoms
Released: Nov 15, 2022
Commentary by Dr. Dan Lenihan
JACC: CardioOncology - Prognosis of Transthyretin Cardiac Amyloidosis without Heart Failure Symptoms
00:00:00
